NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
06/02/2024
Back to search
Official data from USPTO
CLINICARE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
04/03/2026
Trademark type
Word
Nice classes
10
Filing date
02/13/2013
Registration date
02/25/2014
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/02/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/01/2013
First use in commerce
01/01/2013
Drawing code
4
Owner type
11
Owner location
Ra'anana, IL
Examiner
LORENZO, KATHLEEN H
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
CLINICARE LTD.
PORTABLE TECHNOLOGIES Ltd.
Representatives
Mark M. Friedman Dr. Mark Friedman Ltd.
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Medical equipmentblood pressure and diabetic diagnostic medical devicesoxygen regulatorsoxygen monitorsbreast pumpsbaby bottles; Health monitoring devicesblood pressure monitorsthermometers and pedometers; Health monitors comprising sensor that monitor the health of the elderly or disabled in their own homespulse rate monitors
Publications
History of USPTO decisions and trademark events.
41 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
06/02/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06/02/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/02/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
02/25/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/25/2023
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
03/19/2020
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
03/19/2020
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
03/16/2020
PRA8
POST REGISTRATION ACTION MAILED - SEC. 8
03/11/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/09/2020
ES8R
TEAS SECTION 8 RECEIVED
01/13/2020
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/25/2019
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
06/05/2014
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
06/04/2014
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
05/28/2014
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
04/22/2014
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
04/08/2014
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
03/31/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/27/2014
AMD7
SEC 7 REQUEST FILED
03/13/2014
ES7R
TEAS SECTION 7 REQUEST RECEIVED
03/13/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
02/25/2014
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/24/2014
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
01/23/2014
ALIE
ASSIGNED TO LIE
01/22/2014
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/26/2013
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/13/2013
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/09/2013
IUAF
USE AMENDMENT FILED
11/06/2013
EISU
TEAS STATEMENT OF USE RECEIVED
11/06/2013
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/03/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/09/2013
PUBO
PUBLISHED FOR OPPOSITION
07/09/2013
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
06/26/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/19/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/05/2013
DOCK
ASSIGNED TO EXAMINER
05/29/2013
MPMK
NOTICE OF PSEUDO MARK E-MAILED
02/21/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/20/2013
NWAP
NEW APPLICATION ENTERED
02/16/2013
Continuous trademark protection
Get notified about every new filing that threatens CLINICARE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.